Prosecution Insights
Prosecution Insights
5 pending office actions • 2 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (40%) |
| §102 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TAMUKONG, YVETTE BIH | 1 | 100.0% | +0.0% |
| CHEN, CATHERYNE | 1 | 37.4% | +18.3% |
| DAVIS, BRIAN J | 1 | 84.8% | -4.1% |
| COUGHLIN, MATTHEW P | 1 | 71.4% | +11.9% |
| GURLEY, JAMI MICHELLE | 1 | 50.0% | +19.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18285439 | IMMUNOFUNCTIONAL CARRIER, METHODS OF USES, AND COMPOSITION MATTERS AS AN ANTITUMOR IMMUNOTHERAPY | DAVIS, BRIAN J | 3d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17794917 | LIGAND-MEDIATED DELIVERY OF THERAPEUTIC PROTEINS AND THE USES THEREOF | GURLEY, JAMI MICHELLE | 53d overdue |
| 18123018 | Circularly Recyclable Polymers Featuring Topochemically Elongated Carbon-Carbon Bonds | COUGHLIN, MATTHEW P | 36d overdue |
| 19100347 | EFFICIENT GENOTYPE-INDEPENDENT IN PLANTA TRANSFORMATION OF CEREALS | TAMUKONG, YVETTE BIH | — |
| 18579679 | PREBIOTIC COMPOSITION AND METHOD OF USE TO IMPROVE GASTROINTESTINAL HEALTH IN PATIENTS WITH DYSBIOSIS AND LEAKY GUT | CHEN, CATHERYNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17794917 | LIGAND-MEDIATED DELIVERY OF THERAPEUTIC PROTEINS AND THE USES THEREOF | GURLEY, JAMI MICHELLE | 53d overdue |
| 18123018 | Circularly Recyclable Polymers Featuring Topochemically Elongated Carbon-Carbon Bonds | COUGHLIN, MATTHEW P | 36d overdue |
| 18579679 | PREBIOTIC COMPOSITION AND METHOD OF USE TO IMPROVE GASTROINTESTINAL HEALTH IN PATIENTS WITH DYSBIOSIS AND LEAKY GUT | CHEN, CATHERYNE | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Purdue University | 4 |
| Rush University | 1 |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| 1655 | 1 |
| 1614 | 1 |
| 1626 | 1 |
| 1647 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19100347 | EFFICIENT GENOTYPE-INDEPENDENT IN PLANTA TRANSFORMATION OF CEREALS | Purdue Research Foundation | TAMUKONG, YVETTE BIH | 1662 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 31, 2025 |
| 18579679 | PREBIOTIC COMPOSITION AND METHOD OF USE TO IMPROVE GASTROINTESTINAL HEALTH IN PATIENTS WITH DYSBIOSIS AND LEAKY GUT | Rush University Medical Center | CHEN, CATHERYNE | 1655 | §101§102§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18285439 | IMMUNOFUNCTIONAL CARRIER, METHODS OF USES, AND COMPOSITION MATTERS AS AN ANTITUMOR IMMUNOTHERAPY | Purdue Research Foundation | DAVIS, BRIAN J | 1614 | §102 | Non-Final OA | 3d overdue | Pending | Oct 03, 2023 |
| 18123018 | Circularly Recyclable Polymers Featuring Topochemically Elongated Carbon-Carbon Bonds | Purdue Research Foundation | COUGHLIN, MATTHEW P | 1626 | §102§112 | Final Rejection | 36d overdue | Pending | Mar 17, 2023 |
| 17794917 | LIGAND-MEDIATED DELIVERY OF THERAPEUTIC PROTEINS AND THE USES THEREOF | Purdue Research Foundation | GURLEY, JAMI MICHELLE | 1647 | §103§112 | Non-Final OA | 53d overdue | Pending | Jul 22, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial